M67.211
Synovial hypertrophy, not elsewhere classified, right shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening or enlargement of the synovial membrane, which lines the joints, including the shoulder. When this condition affects the right shoulder specifically and is not classified elsewhere, it is designated under the ICD-10 code M67.211. The synovial membrane plays a crucial role in producing synovial fluid, which lubricates and nourishes the joint. Hypertrophy of this membrane can lead to joint discomfort, reduced mobility, and other functional issues. Although the exact cause may vary, this condition is commonly associated with inflammatory or degenerative processes affecting the shoulder joint.
Causes & Symptoms
Clinical Causes: Chronic inflammation due to conditions like rheumatoid arthritis or bursitis Degenerative joint diseases such as osteoarthritis Repeated shoulder injuries or overuse Infections affecting the shoulder joint Autoimmune disorders leading to joint inflammation Other inflammatory responses or unknown triggers
Key Symptoms: Persistent shoulder pain or tenderness Swelling or visible enlargement of the shoulder area Limited range of motion or stiffness in the shoulder A sensation of fullness or tightness in the joint Discomfort during shoulder movements or activity Possible warmth or redness around the affected joint
Diagnostic & Treatment
Diagnosis Path: To diagnose synovial hypertrophy in the right shoulder, healthcare providers typically perform a physical examination assessing joint swelling, tenderness, and mobility. Imaging studies like MRI or ultrasound are invaluable for visualizing the thickened synovial tissue and evaluating joint integrity. Sometimes, joint aspiration may be performed to analyze synovial fluid for signs of inflammation or infection. The combination of clinical findings and imaging results allows for an accurate diagnosis and helps rule out other shoulder conditions.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain Physical therapy to improve shoulder strength and flexibility Corticosteroid injections directly into the shoulder joint to decrease inflammation Rest and activity modification to prevent aggravation Surgical intervention, such as synovectomy, in cases where conservative treatment fails or significant hypertrophy causes restriction Addressing underlying causes like infections or autoimmune diseases through specialized therapies
Clinical Advice & FAQs
Billing Guidance
Is M67.211 a billable ICD-10 code?
Yes, M67.211 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.211?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, right shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference